Investors

Insider Transactions

Date Name Title Type Shares Traded Price Range Sorted Descending
Jun 27, 2014 sanofi Beneficial Owner (10% or more) Automatic Buy 50,000 272.70 - 277.43
Dec 20, 2013 powchik peter Officer Automatic Sell 133 271.09
Dec 17, 2013 powchik peter Officer Automatic Sell 8 270.00
May 10, 2013 sing george l Director Sell 5,000 270.00
Jan 27, 2014 sanofi Beneficial Owner (10% or more) Buy 74,685 269.77 - 275.31
May 17, 2013 brown michael s Director Sell 5,000 269.00 - 270.20
May 10, 2013 stahl neil Officer Disposition (Non Open Market) 32,400 268.40
May 20, 2013 goldberg murray a Officer Automatic Sell 81,132 266.64
Dec 18, 2013 powchik peter Officer Automatic Sell 9,162 264.86 - 270.20
May 6, 2013 vagelos p roy Officer Sell 13,482 263.15 - 264.19
May 7, 2013 terifay robert j Officer Disposition (Non Open Market) 8,692 261.67
May 7, 2013 yancopoulos george Officer Sell 100,000 261.66 - 264.21
May 7, 2013 van plew daniel p Officer Sell 13,725 260.88 - 262.15
May 8, 2013 terifay robert j Officer Sell 8,231 260.86 - 262.06
May 6, 2013 van plew daniel p Officer Disposition (Non Open Market) 15,323 260.44
May 6, 2013 yancopoulos george Officer Disposition (Non Open Market) 103,243 260.44
Dec 12, 2013 yancopoulos george Officer Option Execute 9,599 260.44
May 6, 2013 gilman alfred g Director Sell 30,000 260.41 - 264.82
May 6, 2013 tessier-lavigne marc Director Sell 13,334 260.20 - 264.17
May 6, 2013 shooter eric m Director Sell 10,000 258.78 - 264.18
Showing 121-140 of 842 transactions Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43  See Previous 20 | See Next 20

Stock transaction information provided by EDGAR Online. Regeneron Pharmaceuticals, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.



Close
Form content here please :)